I have just been looking at Neuren and there are a few similarities between PAA and NEU.
PAA has around 1.4B shares on issue, NEU around 1.6B shares on issue, both are pharma companies with ongoing trials on drugs.
One main different is that NEU has a $25m funding partnership with the US Army of which they still have around $22m left.
PAA has only around $10m market cap with NEU having a market cap around $127m, so it would be good if PAA can get a market cap up around the $100m
DYOR
The Next Neuren, page-11
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.020(9.30%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $562.4K | 2.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 64065 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 115000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |